Summary:
The genotype frequencies of MDR1 T-129C, C1236T, G2677A,T and C3435T SNPs were compared in 154 healthy Japanese and 100 healthy Caucasians to provide basic information on the interethnic diŠerences of pharmacotherapeutic outcome. The variants were found at allelic frequencies of 5.5z, 65.6z, 16 .6z, 40.6z and 40.6z, for T-129C, C1236T, G2677A, G2677T and C3435T, respectively, in Japanese, and at 5.1z, 45.9z, 3.6z, 46.4z and 56.6z, respectively, in Caucasians, with a statistically signiˆcant diŠerence for C1236T, G2677A,T and C3435T (pº0.001). G2677A was about 5-fold more frequent in Japanese than Caucasians. These genotype frequencies were also investigated in 95 Japanese patients with colorectal cancer (CRC) and esophageal squamous cell carcinoma (ESCC), but no signiˆcant diŠerence was detected, when compared with healthy Japanese subjects. The haplotype frequency reached a total of about 85z in Japanese with the following 4 (13.3z ). The second and fourth haplotypes were hardly inferred in Caucasian, whereas T -129 -C 1236 -G 2677 -T 3435 (12.8z) was found to be Caucasian-speciˆc. There was a tendency for higher frequencies of the T -129 W C-129 -C
Introduction
Multidrug resistant transporter, MDR1 W P-glycoprotein (ABCB1), the gene product of MDR1, was originally isolated from cancer cells that had developed resistance to anticancer drugs. [1] [2] [3] [4] [5] [6] [7] [8] It has been elucidated that MDR1 is also expressed in normal tissues, including the liver, kidney, small and large intestines, brain, testis, muscle tissue, placenta, and adrenals, and confers an intrinsic resistance by exporting unnecessary and toxic exogenous substances or metabolites out of cells. [1] [2] [3] [4] [5] [6] [7] [8] A number of structurally unrelated drugs have been found to be substrates for MDR1, and MDR1 and its related proteins are now recognized as important factors regulating the pharmacokinetics of drugs. Moreover, recent investigations have implicated MDR1 in the system regulating cell diŠerentiation, proliferation and survival.
Theˆrst systemic screening for MDR1 genetic polymorphisms was performed by HoŠmeyer et al. in 2000, and 15 single nucleotide polymorphisms (SNPs) were identiˆed by analyzing 188 Caucasian individuals. 9) In the ensuring 5 years, several attempts have been made to identify additional SNPs and to examine their association with phenotypes. Recently, more than 40 SNPs were listed in an extensive examination by Kroetz et al. 10) Of these SNPs, a silent SNP in exon 26, C3435T, is the best characterized in terms of its association with the expression and W or function in the tissues, and also with pharmacokinetics and pharmacodynamics, however, there are still discrepancies in the results. [1] [2] [3] [4] [5] [6] [7] [8] Based on the assumption that MDR1 plays an important role in the detoxiˆcation systems of normal tissues, several studies have focused on the eŠects of C3435T on susceptibility to a certain class of disease. As for susceptibility to cancer, Siegsmund et al. 11) and Jamroziak et al. 12) suggested that the T 3435 -allele is a risk factor for renal epithelial tumors and childhood acute lymphoblastic leukemia (ALL), respectively. C3435T has also reportedly been found more frequently in patients with colon cancer. [13] [14] [15] In contrast, Stanulla et al. suggested a signiˆcant reduction in the risk of relapse in the central nervous system in childhood ALL for patients with the T 3435 -allele, 16) and Miller et al. reported no association with adult glioma. 17) Illmer et al. have reported MDR1 genotype-related susceptibility to acute myeloid leukemia, where the heterozygote for C1236T, G2677T and C3435T was more frequently found among patients. 18) As stated above, there is no consensus on the association of C3435T with susceptibility to cancer, or with pharmacotherapy, indicating the need for a rational explanation and additional clinical investigations.
Herein, the genotype and haplotype frequencies of MDR1 T-129C, C1236T, G2677A,T and C3435T SNPs were compared in 154 healthy Japanese and 100 healthy Caucasians to provide basic information on the interethnic diŠerences of pharmacotherapeutic outcome between both populations, and moreover were investigated in 95 Japanese patients with colorectal cancer (CRC) and esophageal squamous cell carcinoma (ESCC) to examine their potential as predictors of cancer susceptibility.
Materials and Methods
Subjects: A total of 95 unrelated Japanese patients with CRC (34 males and 14 females) and ESCC (44 males and 3 females) diagnosed at Kobe University Hospital participated in this study. Diagnoses of colorectal adenocarcinoma and esophageal carcinoma were based on clinical, endoscopic, radiologic, and histopathologicalˆndings as described previously. 19, 20) The average age was 66.4±11.5 (±SD) years old (range, 28-82 years) and 64.8±8.0 years old (range, 48-83 years), respectively. One hundred andˆfty-four unrelated healthy Japanese subjects (47 males and 107 females) aged 26.3±7.5 (range, 21-57) years were also enrolled and served as the healthy Japanese subjects. Written informed consent was obtained from all patients at the beginning of this study. The protocol for this study was approved by the Institutional Review Board of Kobe University Hospital, Japan. The data for MDR1 genotypes in 100 healthy Caucasians were quoted from a study which was performed as the Pharmacogenetics of Membrane Transporter Project at the University of California, San Francisco in the United States.
10)
Isolation of genomic DNA: Peripheral blood (2.0 mL) was drawn from the subject into a sampling tube containing EDTA-2Na (3.0 mg), and genomic DNA was extracted from 0.2 mL of whole blood using a QIAamp DNA Blood mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer's instructions.
MDR1 genotyping of T-129C, C1236T, G2677A,T and C3435T: The genetic polymorphisms T-129C, G2677A,T and C3435T were determined using the TaqMan } MGB probe and primer as reported previously. 21) To determine C1236T, the following probe and primers were designed using the software Assays-byDesignSM (Applied Biosystems, Foster, USA): the C 1236 -allele probe, 5?-CAG GTT CAG gCC CTT-3?; the T 1236 -allele probe, 5?-TTC AGG TTC AGa CCC TT-3?; the forward primer, 5?-CAC CGT CTG CCC ACT CT-3?; and the reverse primer, 5?-GTG TCT GTG AAT TGC CTT GAA GTT T-3?. Lower-case font represents the SNP. As a reporter at the 5? end of the TaqMan } MGB probe, VIC } was used for the C 1236 -allele and 6-carboxy‰uorescein (FAM) was used for the T 1236 -allele. All TaqMan } MGB probes and primers used in this study were synthesized by Applied Biosystems Japan, Ltd. (Tokyo, Japan).
Haplotype analysis: The MDR1 haplotypes were statistically inferred using an algorithm based on Bayesian inference, PHASE version 2.0.2 (http: W W www. stat.Washington.edu W stephens W ) with a fair degree of precision. 10, 22, 23) PHASE calls were made separately for each ethnic and disease group. Haplotypes were inferred by running PHASE a total of 10 times, and relative standard deviation of their frequencies was 5z or less of the mean value. The estimated haplotype frequencies were expressed as the average population haplotype frequencies for the whole sample (referred to as thè`P opulation haplotype'') as well as the practical haplotype frequencies based on the most likely inferred pairs of haplotypes identiˆed at least 8 of 10 times for each individual (referred to as the``Practical haplo- Allelic and Genotype frequency comparisons with Japanese healthy subjects (Fisher's exact test). c) Data from the study reported by Kroetz et al. 10) 128
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type''). Statistical analysis: DiŠerences in genotype and allelic frequencies between healthy Japanese and Caucasian subjects and between the healthy subjects and patients in Japan were examined using Fisher's exact statistical tests. P values of less than 0.05 were considered signiˆcant. Table 1 lists the MDR1 allelic and genotype frequencies determined in healthy Japanese and Caucasian subjects, and in Japanese patients with CRC and ESCC. In healthy Japanese subjects, the variants were found at allelic frequencies of 5.5z, 65.6z, 16.6z, 40.6z and 40.6z, for T-129C, C1236T, G2677A, G2677T and C3435T respectively. For healthy Caucasians, they were found at 5.1z, 45.9z, 3.6z, 46.4z and 56.6z, respectively, with a statistically signiˆcant diŠerence for C1236T, G2677A,T and C3435T (pº0.001). It is noted that G2677A was about 5-fold more frequently found in Japanese than Caucasian. Statistically signiˆcant diŠerences were also detected for their genotypes ( Table 1) . The variants were found at frequencies of 7.3z, 60.4z, 20.8z, 41.7z and 41.7z for 48 Japanese CRC patients and 6.4z, 58.5z, 14.9z, 43.6z and 46.8z for 47 Japanese ESCC patients, respectively. No signiˆcant diŠerence was detected for allelic and genotype frequencies between healthy Japanese subjects and either group of cancer patients. Table 2 shows the estimated frequencies of MDR1 haplotypes in healthy Japanese and Caucasian subjects, and in Japanese patients with CRC and ESCC. No diŠerence in frequency was found between thè`P opulation haplotype'' and``Practical haplotype''. In healthy Japanese subjects, 12 haplotypes were statistically inferred with a frequency of more than 0.1z at the population base. With the major 4 haplotypes, the frequency reached a total of about 85z; 
Results
C T G C not assigned 0.4 (0.3) 0.2 (-) º0.1 (-) º0.1 (-) T C T T * 17A 0.3 (0.3) 1.2 (1.0) º0.1 (-) 1.0 (1.1) C C T T not assigned 0.1 (-) º0.1 (-) º0.1 (-) º0.1 (-) T C T C *21D W *26C º0.1 (-) º0.1 (-) 0.5 (-) 1.7 (1.6) T C A T *2B º0.1 (-) º0.1 (-) º0.1 (-) 1.0 (1.1) C C G T not assigned º0.1 (-) 0.3 (-) º0.1 (-) 0.5 (0.5) C T G T * 12B º0.1 (-) 0.1 (-) º0.1 (-) º0.1 (-) C T A T not assigned º0.1 (-) º0.1 (-) 0.1 (-) º0.1 (-) C T T T not assigned º0.1 (-) º0.1 (-) º0.1 (-) 0.5 (-)
Discussion
In this examination, the frequency of variants T-129C, C1236T, G2677A, G2677T and C3435T in healthy Japanese subjects was 5.5z, 65.6z, 16.6z, 40.6z and 40.6z, respectively ( Table 1) . These results are consistent with other studies on Japanese and our previous report with a smaller population, i.e., 6.0-9.3z for T-129C, 21, [24] [25] [26] 55.5-61.5z for C1236T, 24, 25) 16.9-20.5z for G2677A, 21, [24] [25] [26] 35.5-40.8z for G2677T, 21, [24] [25] [26] and 38.5-44.1z for C3435T. 21, [24] [25] [26] [27] In Caucasians, the allelic frequencies were found to be 5.1z, 45.9z, 3.6z, 46.4z and 56.6z, respectively, again consistent with previous reports, i.e., 5.1-5.9z for T-129C, 9, 10) 37.8-45.9z for C1236T, 9, 10, 28, 29) 1.9-3.6z for G2677A, 10, 28, 29) 41.6-46.4z for G2677T, 10, 28, 29) and 48.0-56.1z for C3435T. 9, 10, 28, 29) Inter-ethnic diŠer-ences in frequencies have been studied extensively for C3435T among SNPs ever since the report by HoŠmey-er et al. on the eŠects of MDR1 genotype showed the association of C3435T with the expression of MDR1 in the duodenum, and thereby with the pharmacokinetics of digoxin, a typical MDR1 substrate, after oral administration. 9) In the past 5 years, a number of clinical studies have been performed to replicate theseˆn dings; however, there are still discrepancies, suggesting the eŠects of other SNPs. [1] [2] [3] [4] [5] [6] [7] [8] The allelic and genotype frequencies for T-129C, C1236T and G2677A,T presented herein might be useful for explaining the diŠerences with theˆndings of HoŠmeyer et al. 9) MDR1 is understood to play an important role in the detoxiˆcation systems of normal tissues, and C3435T has been evaluated in terms of disease susceptibility. Several reports have suggested that this SNP is a risk factor for cancer, including colorectal cancer, [11] [12] [13] [14] [15] although this is not always the case. 16, 17) Here, it was found that C3435T was not associated with CRC or ESCC in Japanese. Additionally, the eŠects of 3 other SNPs were evaluated. Although there was a tendency for a higher frequency of the A 2677 -allele in the CRC patients, the T 3435 -allele in the ESCC patients, and TC -129 , CT 1236 , AT 2677 and CT 3435 genotypes in the CRC and ESCC patients, compared to healthy Japanese subjects, the study was not su‹ciently powered to reach statistical signiˆcance ( Table 1 ). In Japan, the incidence of CRC and ESCC is increasing in Japan, 30) and therefore further studies are needed to examine whether environmental factors, unexamined MDR1 genotypes, and W or genes other than MDR1 gene, were more predominant for the development of CRC and ESCC.
To explain the diversity of the results of C3435T, several reports suggested the importance of linkage disequilibrium of C3435T with C1236T and G2677T, the latter resulting in Ala893Ser, that is, C3435T may not itself be causal but rather may be linked with the causal polymorphisms. [1] [2] [3] [4] [5] [6] [7] [8] Johne et al. deˆned 4 haplotypes; 11, 12, 21 and 22, and 9 genotypes; 00, 01, 02, 10, 11, 12, 02, 21 and 22, based on G2677T and C3435T, 31) where the haplotype coding is as follows; 1: identical to the reference sequence (G 2677 W C 3435 ); 2: diŠerent from it (T 2677 W T 3435 ), and therefore the genotype coding is as follows; 0: homozygous for nucleotides identical to the reference sequence for the position on both chromosomes; 1: heterozygous; 2: homozygous for nucleotides diŠerent from the reference sequence for the position on both chromosomes. For genotype 11, 11 W 22, not 12 W 21, is selected based on the frequency in Caucasians. This assignment is often used to check the importance of haplotype analyses, [1] [2] [3] [4] [5] [6] [7] [8] but it is noted that a variant A 2677 -allele was preferentially found in Japanese as shown in Table 1 . This allele has been shown to be important for the pharmacokinetics of the H1-antihistamine, fexofenadine, 32) and thus an analysis based on Johne's assignment is insu‹cient for Japanese. Haplotype may often provide more useful information than genotype about inter-individual and inter-ethnic diŠerences of pharmacokinetics and pharmacodynamics. 33) Kim et al., 29) Sai et al., 24) and Tang et al. 34) have dened 11 haplotypes, MDR1*1 to *11, and their subtypes based on C1236T, G2677A,T and C3435T, but Saito et al. have suggested the importance of T-129C. 21) Kroetz et al. deˆned 32 haplotypes, MDR1*1 to MDR1 * 32, and their subtypes (a total of 64 haplotypes). 10) These assignments should be justiˆed by genotype-phenotype correlation studies. As shown in Table 2 , there is a considerable diŠerence in the frequencies of haplotype including A 2677 polymorphism between Japanese and Caucasian. This might contribute in part to the inter-ethnic discrepancies of the results on C3435T.
Estimates of MDR1 haplotype frequencies showed that 3 of 12 haplotypes found in Japanese were hardly inferred in Caucasians, whereas T -129 -C 1236 -G 2677 -T 3435 was Caucasian-speciˆc. A tendency for higher frequencies of the T -129 W C -129 -C
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-A 2677 -C 3435 haplotype in the CRC patients and the T -129 -T 1236 -T 2677 -T 3435 haplotype in the ESCC patients was also observed in comparison with that in the healthy Japanese subjects. These results suggested that MDR1 haplotypes based on 4 sites, -129, 1236, 2677 and 3435, may be able to be used to characterize ESCC and CRC patients in the Japanese population, and future large scale studies are warranted to appropriately investigate this possibility.
